Publications

Found 5 results
Filters: Keyword is Receptor, Epidermal Growth Factor  [Clear All Filters]
2011
Roovers, R. C., M. J. W. D. Vosjan, T. Laeremans, R. el Khoulati, R. C. G. de Bruin, K. M. Ferguson, A. J. Verkleij, G. A. M. S. van Dongen, and P. M. P. van Be Henegouwen, "A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth.", Int J Cancer, vol. 129, issue 8, pp. 2013-24, 2011 Oct 15.
Gainkam, L. Olive Tcho, M. Keyaerts, V. Caveliers, N. Devoogdt, C. Vanhove, L. Van Grunsven, S. Muyldermans, and T. Lahoutte, "Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy.", Mol Imaging Biol, vol. 13, issue 5, pp. 940-8, 2011 Oct.
Gainkam, L. Olive Tcho, V. Caveliers, N. Devoogdt, C. Vanhove, C. Xavier, O. Boerman, S. Muyldermans, A. Bossuyt, and T. Lahoutte, "Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice.", Contrast Media Mol Imaging, vol. 6, issue 2, pp. 85-92, 2011 Mar-Apr.
2008
Tijink, B. M., T. Laeremans, M. Budde, M. Stigter- van Walsum, T. Dreier, H. J. de Haard, R. C Leemans, and G. A. M. S. van Dongen, "Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology.", Mol Cancer Ther, vol. 7, issue 8, pp. 2288-97, 2008 Aug.
2007
Roovers, R. C., T. Laeremans, L. Huang, S. De Taeye, A. J. Verkleij, H. Revets, H. J. de Haard, and P. M. P. van Be Henegouwen, "Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies.", Cancer Immunol Immunother, vol. 56, issue 3, pp. 303-317, 2007 Mar.